These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 35175662)

  • 21. Basics of the medical use of ayahuasca: physiology of dimethyltryptamine.
    Ede F; Attila K; Attila S; Csaba F; Csaba M
    Lege Artis Med; 2016; 26(9-10):413. PubMed ID: 29537778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulatory effects of ayahuasca on personality structure in a traditional framework.
    Netzband N; Ruffell S; Linton S; Tsang WF; Wolff T
    Psychopharmacology (Berl); 2020 Oct; 237(10):3161-3171. PubMed ID: 32700023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunological Modulation and Control of Parasitaemia by Ayahuasca Compounds: Therapeutic Potential for Chagas's Disease.
    Katchborian-Neto A; Santos MFC; Vilas-Boas DF; Dos Santos EG; Veloso MP; Bueno PCP; Caldas IS; Soares MG; Dias DF; Chagas-Paula DA
    Chem Biodivers; 2022 Oct; 19(10):e202200409. PubMed ID: 36163588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca.
    Riba J; McIlhenny EH; Valle M; Bouso JC; Barker SA
    Drug Test Anal; 2012; 4(7-8):610-6. PubMed ID: 22514127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ritualistic Use of Ayahuasca versus Street Use of Similar Substances Seized by the Police: A Key Factor Involved in the Potential for Intoxications and Overdose?
    Lanaro R; Calemi DB; Togni LR; Costa JL; Yonamine M; Cazenave Sde O; Linardi A
    J Psychoactive Drugs; 2015; 47(2):132-9. PubMed ID: 25950593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral profile of constituents in ayahuasca, an Amazonian psychoactive plant mixture.
    Freedland CS; Mansbach RS
    Drug Alcohol Depend; 1999 May; 54(3):183-94. PubMed ID: 10372792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking.
    Kuypers KP; Riba J; de la Fuente Revenga M; Barker S; Theunissen EL; Ramaekers JG
    Psychopharmacology (Berl); 2016 Sep; 233(18):3395-403. PubMed ID: 27435062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers.
    Riba J; Anderer P; Morte A; Urbano G; Jané F; Saletu B; Barbanoj MJ
    Br J Clin Pharmacol; 2002 Jun; 53(6):613-28. PubMed ID: 12047486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroprotective potential of Ayahuasca and untargeted metabolomics analyses: applicability to Parkinson's disease.
    Katchborian-Neto A; Santos WT; Nicácio KJ; Corrêa JOA; Murgu M; Martins TMM; Gomes DA; Goes AM; Soares MG; Dias DF; Chagas-Paula DA; Paula ACC
    J Ethnopharmacol; 2020 Jun; 255():112743. PubMed ID: 32171895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ayahuasca: Pharmacology, neuroscience and therapeutic potential.
    Domínguez-Clavé E; Soler J; Elices M; Pascual JC; Álvarez E; de la Fuente Revenga M; Friedlander P; Feilding A; Riba J
    Brain Res Bull; 2016 Sep; 126(Pt 1):89-101. PubMed ID: 26976063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health status of ayahuasca users.
    Barbosa PC; Mizumoto S; Bogenschutz MP; Strassman RJ
    Drug Test Anal; 2012; 4(7-8):601-9. PubMed ID: 22761152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ayahuasca Exposure: Descriptive Analysis of Calls to US Poison Control Centers from 2005 to 2015.
    Heise CW; Brooks DE
    J Med Toxicol; 2017 Sep; 13(3):245-248. PubMed ID: 27896660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: Results from two pilot, proof-of-concept, randomized, placebo-controlled trials.
    Dos Santos RG; Rocha JM; Rossi GN; Osório FL; Ona G; Bouso JC; Silveira GO; Yonamine M; Marchioni C; Crevelin EJ; Queiroz ME; Crippa JA; Hallak JEC
    Hum Psychopharmacol; 2022 Jul; 37(4):e2834. PubMed ID: 35107855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT.
    Barker SA
    Psychopharmacology (Berl); 2022 Jun; 239(6):1749-1763. PubMed ID: 35064294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine.
    McIlhenny EH; Riba J; Barbanoj MJ; Strassman R; Barker SA
    Biomed Chromatogr; 2011 Sep; 25(9):970-84. PubMed ID: 21058415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members.
    Santos RG; Landeira-Fernandez J; Strassman RJ; Motta V; Cruz AP
    J Ethnopharmacol; 2007 Jul; 112(3):507-13. PubMed ID: 17532158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant.
    Riba J; Romero S; Grasa E; Mena E; Carrió I; Barbanoj MJ
    Psychopharmacology (Berl); 2006 May; 186(1):93-8. PubMed ID: 16575552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Ayahuasca and its Alkaloids on Drug Dependence: A Systematic Literature Review of Quantitative Studies in Animals and Humans.
    Nunes AA; Dos Santos RG; Osório FL; Sanches RF; Crippa JA; Hallak JE
    J Psychoactive Drugs; 2016; 48(3):195-205. PubMed ID: 27230395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ayahuasca: What Healthcare Providers Need to Know.
    Goldin D; Salani D
    J Addict Nurs; 2021 Apr-Jun 01; 32(2):167-173. PubMed ID: 34060770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunological effects of ayahuasca in humans.
    dos Santos RG
    J Psychoactive Drugs; 2014; 46(5):383-8. PubMed ID: 25364989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.